Moderna at Risk of Suspension After Regulatory Breaches Over Covid Vaccine Trials

[Social Media]

 

---

Moderna at Risk of Suspension After Regulatory Breaches Over Covid Vaccine Trials

 

Moderna is facing the possibility of suspension from Britain’s leading pharmaceutical trade group following multiple serious breaches of regulatory standards. The Covid-19 vaccine manufacturer is scheduled for an audit by the Prescription Medicines Code of Practice Authority (PMCPA) after its conduct was found to be "unacceptable" and damaging to the industry's reputation.

 

Should the audit reveal that Moderna lacks adequate compliance systems, the company could be suspended or even expelled from the Association of the British Pharmaceutical Industry (ABPI), a move that would mark a significant setback for the firm, which only joined the association in 2023.

 

 

The potential penalties stem from a series of troubling incidents, including revelations that company representatives offered financial incentives to children to participate in Covid vaccine trials. Children were reportedly promised £1,500 and teddy bears to encourage their participation — a direct violation of the Medicines for Human Use (Clinical Trials) regulations, which strictly forbid offering financial inducements to children or their guardians.

 

In a new ruling expected to be published imminently, it has also been determined that Moderna misled regulators about when it first became aware of the incentives. The company claimed it only learned of the situation in January 2024 following notification by the Health Research Authority. However, it has now emerged that senior executives had been alerted by the campaign group UsForThem in August 2023, but failed to act.

 

The PMCPA criticized Moderna’s actions, describing the company’s lack of transparency as "completely unacceptable" and stating it had brought "discredit upon the industry." The investigation also uncovered that a senior Moderna employee co-authored three articles — including one with former vaccines minister Nadhim Zahawi — promoting Moderna’s Covid vaccine without disclosing their employment with the company. Additionally, promotional tweets were posted from a personal account without any mention of the individual's ties to Moderna, a failure the PMCPA said constituted inappropriate advertising.

 

Molly Kingsley, founder of UsForThem, condemned Moderna’s behavior, stating: "Many of the previous judgments against Moderna have revealed how readily it put profit ahead of the health and safety of children. Now it has also laid bare just how little regard it has had for the regulatory system that was supposed to keep it honest. Never before has a company so new to the pharmaceutical industry been rebuked in this way."

 

In the latest findings, Moderna was cited for ten new breaches of the code, many involving three senior executives. The PMCPA has ordered an audit to assess whether the company’s culture, governance, and internal systems are functioning effectively. Following the audit, the Appeal Board will determine if further sanctions, including suspension or expulsion, are warranted.

 

The Appeal Board’s power to suspend or expel is rarely used, having been invoked only nine times in the past four decades. The most recent case involved Novo Nordisk, suspended in 2023 over marketing practices related to its weight-loss and diabetes drugs; its membership was later restored in March.

 

Despite being ordered to pay fines in previous cases, critics argue that the financial penalties are too small to deter a company with revenues approaching £7 billion in 2023. Esther McVey MP, a former member of the all-party parliamentary group on Covid vaccine damage, said: "There have now been six cases over the last few months where the UK Prescription Medicines Code of Practice Authority (PMCPA) have ruled against Moderna regarding multiple breaches of the industry’s Code of Practice.

 

The news that the PMCPA is taking the highly unusual step of ordering an audit of Moderna’s culture, governance and compliance framework is reputationally damaging, but it is incredible that the regulator has no real power to impose appropriate fines or other meaningful penalties which might make pharmaceutical companies think twice before breaking the rules. They know they can get away with it, and so they do; time and time again. It’s hardly surprising that public trust in the pharmaceutical industry and its regulators is through the floor."

 

When approached for comment, Moderna told The Telegraph it would wait for the PMCPA rulings to be officially published before responding.

 

  Adpated by ASEAN Now from The Telegraph  2025-04-27

 

 

 

[Red Phoenix]

Suspending them is a good start! 

 

I quote dr Roger Hodkinson: 

"It's Not a Time to Say 'I'm Sorry' – It's a Time to Put These Bastards in Jail"

" We've seen the biggest kill ever in medicine history..."

"Should we forgive and forget?"

"Absolutely not!" roared Dr. Roger Hodkinson. "How can you look into the eyes of a pregnant woman and tell her that this experimental product is safe?

How can you do that as a physician?

No! Any physician that has done that should be in jail."

 

 

 

[blaze master]

I'm quite surprised at this news.